HSP90AA1 and pachyonychia congenita: We investigated patients with PC who received chemotherapy and revealed that the level of Hsp90α was significantly greater in the peripheral blood of patients with chemoresistance (n  = 53) than in those of chemosensitive patients (n = 65).